throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`NALOX-1 PHARMACEUTICALS, LLC,
`Petitioner,
`
`v.
`
`ADAPT PHARMA OPERATIONS LIMITED, and
`OPIANT PHARMACEUTICALS, INC.,
`Patent Owners.
`
`Case No. IPR2019-00685
`U.S. Patent No. 9,211,253
`
`
`
`
`
`
`
`
`
`
`
`
`
`JOINT AMENDED MANDATORY NOTICES OF PATENT OWNERS
`ADAPT PHARMA OPERATIONS LIMITED AND
`OPIANT PHARMACEUTICALS, INC.
`
`

`

`
`
`
`
`
`
`Case No. 2019-00685
`U.S. Patent No. 9,211,253
`
`Pursuant to 37 C.F.R. § 42.8(a)(3), Patent Owners Adapt Pharma Operations
`
`Limited (“Adapt”) and Opiant Pharmaceuticals, Inc. (“Opiant”) jointly submit the
`
`following amended mandatory notices:
`
`I.
`
`Real Parties in Interest, 37 C.F.R. § 42.8(b)(1)
`Adapt and Opiant are the assignees of U.S. Patent Nos. 9,211,253;
`
`9,468,747; and 9,629,965.
`
`Adapt is a wholly owned subsidiary of Adapt Pharma Limited, which is a
`
`wholly owned subsidiary of Emergent Acquisition Limited. Emergent Acquisition
`
`Limited is a wholly owned subsidiary of Emergent International Inc., which is a
`
`wholly owned subsidiary of Emergent BioSolutions Inc. Emergent BioSolutions
`
`Inc. is a publicly held company, and no publicly held company owns 10% or more
`
`of Emergent BioSolutions Inc.’s stock.
`
`Opiant is a publicly held company, and no publicly held company owns 10%
`
`or more of Opiant’s stock.
`
`II. Related Matters, 37 C.F.R. § 42.8(b)(2)
`Petitioner Nalox-1 Pharmaceuticals, LLC (“Nalox-1”) has filed the
`
`following related petitions for inter partes review:
`
`U.S. Patent No.
`9,211,253
`9,211,253
`9,211,253
`9,468,747
`
`Case No.
`IPR2019-00685
`IPR2019-00686
`IPR2019-00687
`IPR2019-00688
`
`2
`
`

`

`
`
`
`
`
`
`
`
`
`
`Case No. 2019-00685
`U.S. Patent No. 9,211,253
`
`U.S. Patent No.
`9,468,747
`9,468,747
`9,561,177
`9,561,177
`9,561,177
`9,629,965
`9,629,965
`9,629,965
`9,775,838
`9,775,838
`9,775,838
`
`Case No.
`IPR2019-00689
`IPR2019-00690
`IPR2019-00691
`IPR2019-00692
`IPR2019-00693
`IPR2019-00694
`IPR2019-00695
`IPR2019-00696
`IPR2019-00697
`IPR2019-00698
`IPR2019-00699
`
`The Board has denied institution of Nalox-1’s petitions in Case Nos.
`
`IPR2019-00686, IPR2019-00687, IPR2019-00689, IPR2019-00690, IPR2019-
`
`00691, IPR2019-00692, IPR2019-00693, IPR2019-00695, IPR2019-00696,
`
`IPR2019-00697, IPR2019-00698, and IPR2019-00699.
`
`U.S. Patent No. 9,211,253; U.S. Patent No. 9,468,747; U.S. Patent No.
`
`9,561,177; U.S. Patent No. 9,629,965; and U.S. Patent No. 9,775,838 have been
`
`asserted in Adapt Pharma Operations Ltd., et al. v. Teva Pharmaceuticals USA,
`
`Inc., et al., Case 2:16-cv-07721-JLL-JAD (D.N.J.) (consolidated), filed October
`
`21, 2016 (“the Teva Action”); and Adapt Pharma Operations Ltd., et al. v. Perrigo
`
`UK FINCO Limited Partnership, Case 2:18-cv-15287-JLL-JAD (D.N.J.)
`
`(consolidated), filed October 25, 2018 (“the Perrigo Action”). On March 2, 2020,
`
`all claims in the Perrigo Action were dismissed with prejudice pursuant to a
`
`Consent Judgment. On June 26, 2020, the district court entered final judgment in
`
`the Teva Action holding the following claims invalid: Claims 7 and 9 of U.S.
`3
`
`
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`Case No. 2019-00685
`U.S. Patent No. 9,211,253
`Patent No. 9,468,747; Claim 4 of U.S. Patent No. 9,561,177; Claims 21, 24, and
`
`25 of U.S. Patent No. 9,629,965; and Claims 2, 24, 33, and 38 of U.S. Patent No.
`
`9,775,838. Patent Owners intend to appeal this judgment.
`
`Administrative matters that would be or could be affected by this proceeding
`
`include pending U.S. Patent Application No. 16/868,816.
`
`III. Lead & Backup Counsel, 37 C.F.R. § 42.8(b)(3)
`Adapt designates the following attorney as lead counsel:
`
`Jessamyn S. Berniker
`Reg. No. 72,328
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`jberniker@wc.com
`
`Opiant designates the following attorney as first backup counsel:
`
`Jessica Tyrus Mackay
`Reg. No. 64,742
`GREEN, GRIFFITH & BORG-BREEN, LLP
`676 North Michigan Avenue, Suite 3900
`Chicago, IL 60611
`jmackay@greengriffith.com
`
`Adapt designates the following attorneys as backup counsel:
`
`Ana C. Reyes
`(Admitted Pro Hac Vice)
`725 Twelfth Street, N.W.
`Washington, DC 20005
`areyes@wc.com
`
`4
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. 2019-00685
`U.S. Patent No. 9,211,253
`
`David M. Krinsky
`Reg. No. 72,339
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`dkrinsky@wc.com
`
`Anthony H. Sheh
`Reg. No. 70,576
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`asheh@wc.com
`
`Opiant designates the following attorney as backup counsel:
`
`Ann K. Kotze
`Reg. No. 76,570
`GREEN, GRIFFITH & BORG-BREEN, LLP
`676 North Michigan Avenue, Suite 3900
`Chicago, IL 60611
`akotze@greengriffith.com
`
`Powers of attorney appointing these attorneys to transact all business in this
`
`proceeding on behalf of Adapt or Opiant, respectively, have been submitted or will
`
`be submitted with this amended mandatory notice information.
`
`5
`
`

`

`
`
`
`
`
`
`
`
`
`
`Case No. 2019-00685
`U.S. Patent No. 9,211,253
`
`IV. Service Information, 37 C.F.R. § 42.8(b)(4)
`Counsel for Adapt and Opiant submit the following service information:
`
`Electronic mail addresses:
`
`Postal mail addresses:
`
`jberniker@wc.com, areyes@wc.com
`dkrinsky@wc.com,
`asheh@wc.com,
`EmergentNarcan@wc.com,
`jmackay@greengriffith.com,
`akotze@greengriffith.com
`
`
`
`Jessamyn S. Berniker
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`
`Jessica Tyrus Mackay
`GREEN, GRIFFITH & BORG-BREEN, LLP
`676 North Michigan Avenue
`Suite 3900
`Chicago, IL 60611
`
`Telephone numbers:
`
`(202) 434-5000, (313) 883-8000
`
`Facsimile number:
`
`(202) 434-5029
`
`Counsel for Adapt consent to electronic service by email at
`
`jberniker@wc.com, areyes@wc.com, dkrinsky@wc.com, asheh@wc.com, and
`
`EmergentNarcan@wc.com.
`
`Counsel for Opiant consents to electronic service by email at
`
`jmackay@greengriffith.com and akotze@greengriffith.com
`
`6
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`Case No. 2019-00685
`U.S. Patent No. 9,211,253
`
`Date: June 30, 2020
`
`Respectfully submitted,
`
`
`/Jessamyn S. Berniker/
`Jessamyn S. Berniker (Reg. No. 72,328)
`Ana C. Reyes (Admitted Pro Hac Vice)
`David M. Krinsky (Reg. No. 72,339)
`Anthony H. Sheh (Reg. No. 70,576)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`T: (202) 434-5000
`F: (202) 434-5029
`jberniker@wc.com
`areyes@wc.com
`dkrinsky@wc.com
`asheh@wc.com
`
`Counsel for Patent Owner
`Adapt Pharma Operations Limited
`
`
`/Jessica Tyrus Mackay/
`Jessica Tyrus Mackay (Reg. No. 64,742)
`Ann K. Kotze (Reg. No. 76,570)
`GREEN, GRIFFITH & BORG-BREEN, LLP
`676 North Michigan Avenue
`Suite 3900
`Chicago, IL 60611
`(313) 883-8000
`jmackay@greengriffith.com
`
`Counsel for Patent Owner
`Opiant Pharmaceuticals, Inc.
`
`
`
`
`
`7
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`Case No. 2019-00685
`U.S. Patent No. 9,211,253
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certifies that a true
`
`and correct copy of the foregoing was served on June 30, 2020, by delivering a
`
`copy via electronic mail on the following attorneys of record:
`
`Yelee Y. Kim
`Janine A. Carlan
`Richard Berman
`Bradford Frese
`Christopher Yaen
`ARENT FOX LLP
`1717 K Street NW
`Washington, DC 20036
`Yelee.Kim@arentfox.com
`Janine.Carlan@arentfox.com
`Richard.Berman@arentfox.com
`Bradford.Frese@arentfox.com
`Christopher.Yaen@arentfox.com
`
`
`
`Jessamyn S. Berniker
`Ana C. Reyes
`David M. Krinsky
`Anthony H. Sheh
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`jberniker@wc.com
`areyes@wc.com
`dkrinsky@wc.com
`asheh@wc.com
`EmergentNarcan@wc.com
`
`Jessica Tyrus Mackay
`Ann K. Kotze
`GREEN, GRIFFITH & BORG-BREEN, LLP
`676 North Michigan Avenue
`Suite 3900
`Chicago, IL 60611
`jmackay@greengriffith.com
`akotze@greengriffith.com
`
`/Jessamyn S. Berniker/
`Jessamyn S. Berniker
`Reg. No. 72,328
`
`
`
`8
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket